Home
ACXP
ACXP News

Latest Acurx Pharmaceuticals Inc. (ACXP) News on April 20, 2025

Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors

PR Newswire

3 days ago

Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors

ACCESS Newswire

4 days ago

New to The Street Renews Acurx Pharmaceuticals (NASDAQ: ACXP) for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach

ACCESS Newswire

8 days ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman - as Sponsored Programming

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman — as Sponsored Programming

ACCESS Newswire

9 days ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman — as Sponsored Programming

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman - as Sponsored Programming

ACCESS Newswire

9 days ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman - as Sponsored Programming

Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks

12 days ago

Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025

Insider Monkey

18 days ago

Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025

GuruFocus.com

a month ago

Acurx Pharmaceuticals Inc (ACXP) Q4 2024 Earnings Call Highlights: Advancing Antibiotic Trials ...

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know

Zacks

a month ago

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

PR Newswire

a month ago

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

ACCESS Newswire

a month ago

New to The Street & Sight & Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP

Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering

PR Newswire

a month ago

Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering

MT Newswires

a month ago

Acurx Pharmaceuticals Launches $1.1 Million Registered Direct Offering; Shares Fall

Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering

PR Newswire

a month ago

Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

CNW Group

2 months ago

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update

PR Newswire

2 months ago

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update

PR Newswire

2 months ago

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors

PR Newswire

2 months ago

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors

ACCESS Newswire

2 months ago

New to the Street to Broadcast Show 627 on Bloomberg Television at 6:30 PM EST Today as Sponsored Programming

MT Newswires

3 months ago

Acurx Pharmaceuticals Says Selling Shareholders May Sell 2.6 Million Shares

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

PR Newswire

3 months ago

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MT Newswires

3 months ago

Acurx Launches $2.5 Million Registered Direct Offering; Shares Fall After-Hours

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

PR Newswire

3 months ago

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

PR Newswire

3 months ago

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?

ACCESSWIRE

4 months ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

PR Newswire

4 months ago

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now

Zacks

5 months ago

Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now

ACCESSWIRE

5 months ago

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Barrons.com

5 months ago

MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

PR Newswire

5 months ago

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update

PR Newswire

5 months ago

Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update

GuruFocus.com

5 months ago

Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update

PR Newswire

5 months ago

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update

New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"

ACCESSWIRE

6 months ago

New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"

New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)

ACCESSWIRE

6 months ago

New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)

Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference

PR Newswire

6 months ago

Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference

Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement

PR Newswire

6 months ago

Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement

Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024

PR Newswire

6 months ago

Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024

New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support

ACCESSWIRE

6 months ago

New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support

New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST

ACCESSWIRE

6 months ago

New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST

New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST

ACCESSWIRE

6 months ago

New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST

Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues

PR Newswire

7 months ago

Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues

Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium

PR Newswire

7 months ago

Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium

New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET

ACCESSWIRE

7 months ago

New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET

ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire

8 months ago

ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference

We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate

Simply Wall St.

8 months ago

We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate

New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT

GlobeNewswire

8 months ago

New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT

New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET

GlobeNewswire

8 months ago

New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update

PR Newswire

8 months ago

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update

USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome

PR Newswire

9 months ago

USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome

Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update

PR Newswire

9 months ago

Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference

PR Newswire

9 months ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference

New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT

GlobeNewswire

10 months ago

New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT

GuruFocus.com

a year ago

Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ...

Thomson Reuters StreetEvents

a year ago

Q1 2024 Acurx Pharmaceuticals Inc Earnings Call

Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection

PR Newswire

a year ago

Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection

Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update

PR Newswire

a year ago

Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

PR Newswire

a year ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

PR Newswire

a year ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update

PR Newswire

a year ago

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update

Newsfile

a year ago

Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 Acurx Pharmaceuticals Inc Earnings Call

We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully

Simply Wall St.

a year ago

We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

PR Newswire

a year ago

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update

PR Newswire

a year ago

Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

PR Newswire

a year ago

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series

GlobeNewswire

a year ago

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT

GlobeNewswire

a year ago

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT

New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT

GlobeNewswire

a year ago

New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT

GlobeNewswire

a year ago

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT

REPLAY- AI From Racetracks to Trading Floors: CEO of Zapata AI and Co-CEO of Andretti Acquisition Corp. in Fireside Chat

IPO-Edge.com

a year ago

REPLAY- AI From Racetracks to Trading Floors: CEO of Zapata AI and Co-CEO of Andretti Acquisition Corp. in Fireside Chat

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

PR Newswire

a year ago

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT

GlobeNewswire

a year ago

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT

FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer

GlobeNewswire

a year ago

FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024

PR Newswire

a year ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT

GlobeNewswire

a year ago

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT

Industrial Logistics Properties Trust's Dividend Analysis

GuruFocus.com

a year ago

Industrial Logistics Properties Trust's Dividend Analysis

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?

Benzinga

a year ago

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

PR Newswire

a year ago

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

Industrial Logistics Properties Trust Announces 2023 Dividend Allocation

Business Wire

a year ago

Industrial Logistics Properties Trust Announces 2023 Dividend Allocation

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

The Economist

a year ago

AI can transform education for the better

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

Business Wire

a year ago

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer

GlobeNewswire

a year ago

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

ACCESSWIRE

a year ago

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

GlobeNewswire

a year ago

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024

InvestorPlace

a year ago

Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024

SYLA’s Rimawari-kun Platform’s Gross Merchandise Value Surpasses Five Billion Yen

GlobeNewswire

a year ago

SYLA’s Rimawari-kun Platform’s Gross Merchandise Value Surpasses Five Billion Yen

Smart Share Global Limited Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

GlobeNewswire

a year ago

Smart Share Global Limited Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

Taylor Devices (NASDAQ:TAYD) Shareholders Will Want The ROCE Trajectory To Continue

Simply Wall St.

a year ago

Taylor Devices (NASDAQ:TAYD) Shareholders Will Want The ROCE Trajectory To Continue

Mama`s Creations Inc (MAMA) Reports Strong Revenue and Net Income Growth in Q3 Fiscal 2024

GuruFocus.com

a year ago

Mama`s Creations Inc (MAMA) Reports Strong Revenue and Net Income Growth in Q3 Fiscal 2024

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

PR Newswire

a year ago

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

Mama’s Creations Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire

a year ago

Mama’s Creations Reports Third Quarter Fiscal 2024 Financial Results

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting

PR Newswire

a year ago

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting

Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?

Zacks

a year ago

Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?

Upland FileBound Named a Gold Medalist in the 2023 SoftwareReviews ECM Data Quadrant Report

Business Wire

a year ago

Upland FileBound Named a Gold Medalist in the 2023 SoftwareReviews ECM Data Quadrant Report

Wind, Climate Change, And The Future

ACCESSWIRE

a year ago

Wind, Climate Change, And The Future

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

ACCESSWIRE

a year ago

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Share on Social Networks: